Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. | Front Immunol | 2023 | 37187731 | PubTator, text mining | PubMed |
| Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer. | Front Immunol | 2023 | 37180158 | PubTator, text mining | PubMed |
| Immunosenescence: molecular mechanisms and diseases. | Signal Transduct Target Ther | 2023 | 37179335 | PubTator, text mining | PubMed |
| Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy. | Cancers (Basel) | 2023 | 37174069 | PubTator, text mining | PubMed |
| Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. | Sci Rep | 2023 | 37169953 | PubTator, text mining | PubMed |
| Osteoimmunology research in rheumatoid arthritis: From single-cell omics approach. | Chin Med J (Engl) | 2023 | 37166215 | PubTator, text mining | PubMed |
| Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. | Nature | 2023 | 37165196 | PubTator, text mining | PubMed |
| The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis. | Cell Rep Med | 2023 | 37160121 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer. | Cancer Commun (Lond) | 2023 | 37158690 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. | Hepatology | 2023 | 37158243 | PubTator, text mining | PubMed |
| A Predictive Disease Risk Model for Ankylosing Spondylitis: Based on Integrated Bioinformatic Analysis and Identification of Potential Biomarkers Most Related to Immunity. | Mediators Inflamm | 2023 | 37152368 | PubTator, text mining | PubMed |
| Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis. | Front Cell Dev Biol | 2023 | 37152289 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| Clinical outcomes of chemotherapy in cancer patients with different ethnicities. | Cancer Rep (Hoboken) | 2023 | 37150853 | PubTator, text mining | PubMed |
| MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment. | Nat Commun | 2023 | 37149682 | PubTator, text mining | PubMed |
| Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies. | Mol Cancer | 2023 | 37149643 | PubTator, text mining | PubMed |
| Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis. | Sci Immunol | 2023 | 37146127 | PubTator, text mining | PubMed |
| Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm. | Mediators Inflamm | 2023 | 37144238 | PubTator, text mining | PubMed |
| Association between tissue stress reaction and ACE2/TMPRSS2 expression in endometria of reproductive aged women before and during Covid-19 pandemic. | BMC Womens Health | 2023 | 37142998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=35